3D Model of Influenza with Hemagglutinin
Last year’s influenza vaccine in the US was only 19% effective. The reason for that [MORE]
It has been nearly a century since the Great Influenza, when an avian influenza mutated to infecting pigs and people. [MORE]
Nanoparticles
Nanoparticles are becoming increasingly useful in both imaging and therapy. This piece reports on a process developed at the University [MORE]
On-Demand-Vaccine
With funding from the Bill & Melinda Gates Foundation, researchers at the University of Washington have developed and carried [MORE]
Molecular Cage
Hydrogel nanotraps have existed for a few years, but this piece describes nanocages derived from self-assembling bacterial proteins. [MORE]
Infant mortality worldwide would take a nose dive if neonates could be vaccinated at birth. But vaccine testing is [MORE]
Over the next five years, the National Institutes of Health, the Defense Advanced Research Projects Agency (DARPA) and the [MORE]
Barry Marshall
In 2005, Barry Marshall and his collaborator, J. Robin Warren, won the Nobel Prize in Physiology or Medicine [MORE]
Microneedle
Hypodermic needles pose certain problems in their use-safe disposal for one; unsanitary reuse in spreading disease for another. To [MORE]
Mosquito
Why might the world benefit from a healthy mosquito? Professor Shigeto Yoshida, at Jichi Medical University (Tochigi, Japan) believes [MORE]
The H1N1 pandemic may precipitate a fundamental change in the way influenza vaccines are produced. Normally, flu virus for [MORE]